ClinicalTrials.gov
public full text
Public Domain
Duloxetine Versus Placebo in the Treatment of FMS
To test the hypothesis that the efficacy and safety of duloxetine has beneficial effects of the reduction of pain severity as measured by the average pain item of the BPI and the PGI-I in patients with fibromyalgia syndrome.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Fibromyalgia Health Outcome Study on Cost of Treatments#916636
- Effect of Combined Morphine and Duloxetine on Chronic Pain#1164386
- Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder#1320127
- Efficacy of NAT-FM Treatment for Fibromyalgia#1095540
- A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia#864946
Record · ID 1397186
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive